Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform which leverages Morphic's unique understanding of integrin structure and biology. Show more

Location: 35 Gatehouse Dr # A2, Massachusetts, 02451-1215, US | Website: morphictx.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$56.99

Open

$56.99

Volume

400

Day Range

$56.99 - $56.99

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

17.13%

Institutional Own.

91.02%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date